Abstract. Breast cancer in young female patients represents a public health problem in developing countries. The objectives of the study were to study the epidemiological and histological characteristics of breast cancer in female patients under 35 years of age. This was a retrospective analytical study of a series of 158 cases of breast cancer in female patients under 35 years of age, conducted at the University Teaching Hospital of Lomé between 2000 and 2015. A total of 158 cases were collected, representing 36.2% (436) of all breast cancer cases. The average age of the patients was 30.9 years (range, 16-35 years). A family history of breast cancer at the 1st or 2nd degree was identified in 13.9% of cases. Genetic mutation studies were carried out for 7 patients, 5 of which revealed mutations (4 BRCA1 and 1 BRCA2). According to the locus, the cancer was located preferentially in the left breast in 88 cases (55.7%). Malignant mammary lesions were epithelial tumors (n=144 cases, 91.1%), infiltrating (n=125 cases, 79.1%) and non-infiltrating (n=19 cases, 12.0%). The other histological groups consisted of 8 cases of sarcomas (5 cases of angiosarcoma, 2 cases of fibrosarcoma and 1 case of Kaposi's sarcoma), 5 cases of lymphomas and one case of melanoma. Not otherwise specified infiltrating ductal carcinomas were SBR II and III in 43.2 and 35.2% of cases, respectively. The tumors classified as T4 were the most frequent (30.4%). Regarding the lymph node status, lymph node metastasis was noted in 22.8% of cases. Studies of hormone receptors were carried out in 23 patients and were positive for 11 patients: Estrogen receptor (ER)+plus progesterone receptor (PR)+(7 patients), ER+PR-(4 patients). Of the aforementioned 8 cases of sarcoma, 5 were angiosarcoma. The lymphomas were predominantly Burkitt's type for 4 cases. Mammary ultrasonography was performed in 45.6% of the patients and 54.4% underwent the combined ultrasonography and mammography. Ultrasound identified one or more sign of malignancy in 67 patients (42.4%), and combined ultrasonography and mammography classified 51.9% of lesions in BIRADS 4 and 5. The incidence of breast cancer in young Togolese patients is high. It is a disease distinguished by a delay in diagnosis, which contributes to the high number of cases that initially diagnosed at an advanced stage, particularly the high histo-prognosis grades of infiltrating ductal carcinoma. These results indicate a genetic origin; therefore, a thorough investigation into genetic mutations should be carried. In addition, further collaborative studies are required to verify these results.
Introduction
Breast cancer is the most-diagnosed type of cancer in female patients worldwide, accounting for ~25% of cancer cases in females; it has a higher prevalence in developed countries and an average age of onset of 50-70 years (1, 2) . Breast cancer in young female patients is increasingly common and presents a real problem for the diagnosis and adequate management of the disease in developing countries (2) . In the USA and Europe, the incidence of breast cancer in female patients ≤35 years of age varies from 3-24% (3, 4) . The incidence is increasing in younger female patients globally with their own epidemiological, diagnostic and prognostic characteristics (5) . In France 2006, ~4,000 females under 35 were diagnosed with breast cancer. Since tumors are more aggressive in younger women, it is important that they are diagnosed and treated early (3) . Breast cancer in younger patients is notable health issue considering the major medical issues and psychological distress associated with this diagnosis. In young female patients, from an epidemiological viewpoint, genetic predisposition must be considered. Hereditary forms of breast cancer are rare and affect <10% of young female patients with the disease, with only three contributing genes currently recognized: BRCA 1 and BRCA 2, for which mutations have frequently been identified in young female patients with breast cancer (4 be performed as a first-line diagnosis test. The breast tissue of young females is dense, with a satisfactory echogenicity allowing the effective exploration of the mass lesions (6) . This can limit the use of mammography in the detection of breast lesions; however, complementary mammography may be used, particularly when screening non-mass lesions. These two medical imaging techniques make it possible to characterize the lesions found, and to identify any signs of malignancy or benignity (6, 7) . In Africa in general, and in Togo in particular, data regarding patients with cancer are scarce due to the unavailability of effective collection and collation tools, including a national cancer registry (8) . The aims of the current study were to identify all cases of breast cancer in female patients ≤35 years of age at the University Teaching Hospital of Lomé, and to record and analyze their epidemiological, histological and prognostic characteristics, whilst advocating for the establishment of a national cancer registry in Togo.
Patients and methods
The present study comprised a retrospective analysis of a series of breast cancer cases in female patients ≤35 years that were diagnosed between January 2000 and December 2015 (15 years) at the University Teaching Hospital of Lomé (Lomé, Togo). These cases were collected from the registers contained within the hospital. The study material consisted of biopsy and surgical tissue specimens fixed in 10% formalin and treated according to conventional histology techniques (hematoxylin and eosin staining). Each cancer tissue sample was characterized according to the World Health Organization histological classification and graded according to the Scarff-Bloom-Richardson (SBR) system and prognostic stage of tumor-node-metastasis (TNM).
For immunohistochemical analysis carried out on certain tissue samples, the parameters were as follows: estrogen receptor (ER); progesterone receptor (PR); over expression of human epidermal growth factor receptor 2 (HER2). The imaging aspects observed during the ultrasound exam and mammography are considered. Ultrasound lesions were categorized as those with no associated malignant criteria and those with ≥1 associated malignant criterion. On the ultrasonography-mammography pair, lesions were classified according to the Breast Imaging Reporting and Data System of the American College of Radiology.
Ethical consideration. The present study received approval from the Head of the Laboratory Department of the University Teaching Hospital of Lomé where the study was to be conducted. As the study included only records analysis, patient consent was not required. However, during the data collection and analysis, patient names were omitted in order to preserve confidentiality.
Results
Epidemiology. In the present study, 158 cases of breast cancer were collated, representing ~38.3% (n=412) of all confirmed cases of breast cancer in female patients identified in the Department of Pathology of the University Teaching Hospital of Lomé. The annual frequency was 10.5±1.6 cases. The mean age at diagnosis was30.9 years (range, 16-35 years), with 69.6% (n=110) of the patients being between 30 and 35 years of age. A total of 22 patients (13.9%) had a familial history of breast cancer. Gene mutation studies were performed for 21 patients, and genetic mutations were observed in 3 patients (2 BRCA1 and 1 BRCA2). According to the location, the cancer was in the left breast in 88 cases Intracanal carcinomas consisted of comedocarcinoma subtypes in 11 cases (64.7%), intracanal carcinoma of subtype mass in 3 cases and papillary carcinoma in 3 cases. Infiltrating epithelial tumors occurred at an average age of 30.6 years. Non-specific infiltrating ductal carcinoma (n=102, 81.6%) was the most frequent histological type of lobular carcinoma infiltrating (n=10, 8%) and mixed carcinoma (n=13).
Non-specific infiltrating ductal carcinomas were SBR III (n=38, 43.2%), SBR II (n=31, 35.2%) and SBR I (n=19, 21.6%). The evaluation of the prognostic stage TNM of the carcinomas in 46 cases had noted: T4 (n=14, 30.4%), T3 (n=13, 28.3%), T2 (n=8, 17.4%). Lymph node metastasis was recorded in 36 cases (22.8%). Paget's disease of the nipple was present in 5 cases. Studies of hormone receptors were carried out in 23 patients and were positive for 11 patients: ER+PR+ (7 patients), ER+PR-(4 patients).
Immunohistochemical analysis of HER2 was carried out in 17 patients, and was positive in 6 cases. These anatomopathological characteristics and findings are summarized in Table II . The 8 sarcomas cases consisted 5 angiosarcomacases, 2 fibrosarcomacases and one case of Kaposi's sarcoma. Lymphomas were all classified as Burkitt's lymphoma.
Imaging. The 158 patients had all undergone breast imaging (Table III) . Overall, 72 (45.6%) patient underwent mammary ultrasonography alone and 86 patients (54.4%) underwent combined ultrasonography and mammography.
Discussion
Discussion of epidemiology. Breast cancer, due to the high global prevalence, presents a notable public health issue (3). The incidence of breast cancer varies markedly across the world; indeed, data from Northern countries that have a high technical plateau and cancer registries are challenging to compare with those of Southern countries typically do not (8, 9) . Continuous and comprehensive recording of all cancer cases (cancer registry) is a guarantee of the quality of the data, and allows estimation of the incidence as well as the various epidemiological parameters (3) (4) (5) (6) (7) (8) (9) . In France, the national incidence for cancer is estimated using data from the French network of cancer registries (FRANCIM) (10) .
While the highest rates are recorded in the USA and Europe, they are also notably high in certain countries in South America, Asia and Africa (Brazil, Argentina, Pakistan, Kuwait and Egypt) (8, 10 ). In the current study, the proportion of breast cancer cases under 35 years of age was 38.3%, comparable to data from the African series (11) .
The relative risk associated with the presence of a family history of breast cancer is approximately 1.9 for all forms of kinship, and the excess risk is more pronounced in younger women and when the disease developed in a first-degree relative before the age of 50 (1,2,12 ). Thoracic radiation, particularly when used in the treatment of cancer in children or young adults, increases the risk of developing breast cancer after 8 years (12) .
This risk then continues to increase with age (12). According to Henderson et al (13) , the cumulative risk at age 40 would be 10-19%, equivalent to that of a female carrying a BRCA1 mutation. Other risk factors appear to be specific to non-menopausal female patients (13) . Furthermore, a study published in 2006 suggested that the recent use of oral contraceptives, particularly in young nulligravidae was associated with an increased risk of breast cancer prior menopause (14) . While obesity is a recognized risk factor in post-menopausal patients, it can function as a protective factor in young female patients (13, 14) . The risk of breast cancer is also higher in young female patients of African descent, compared with in Caucasian female patients, as has been demonstrated in the USA (15) .
Discussion of histopathology. Histologically, the predominance of infiltrating ductal carcinoma case reported in this series is corroborated in numerous reports in the literature databases (9, 11) . Nodal invasion with capsular rupture in the current series was identified in 22.8% of cases, and in 40% in the case series presented by Bollet et al (16) . Nodal invasion with capsular rupture in our series was found in 22.8% of cases and in 40% in the series of Bollet et al (16) . The other series, unlike ours, report very little T3T4 (17, 18) . Lammers et al (18) reported 9% T3 and 2% T4. The advanced stages observed in the current series were determined to be associated with delays in diagnosis; frequently, patients consulted health structures in very advanced clinical phases explaining the predominance of the highly evolved stages. Given the delayed diagnosis, ~75% of these cancer cases are diagnosed at an advanced stage, with 50-80% lymph node involvement and higher SBR grading (40% SBR 2 and 50% SBR 3). Hormone receptors are less likely to be positive (68% of those <40 years of age vs. 80% of ≥40 years), and HER2 is more frequently over expressed in younger patients than in postmenopausal females (19, 20) . Triple-negative tumors (negative for ER, PR and HER2) are more common in younger patients (21) . Triple-negative breast cancer cases have a relapse pattern that is distinct from hormone-positive breast cancer cases: The risk of relapse is markedly higher for the first 3-5 years, but subsequently decreases abruptly and becomes notably lower than that for hormone-positive cancer cases (21, 22) . Mammary sarcomas and lymphomas were rare in current series, concordant with the data from the literature that indicated the rates of these subtypes vary between 0.4 and 2% of all malignant breast tumors (23, 24) .
Discussion of imaging.
The imaging diagnosis of breast cancer cases is based on paired ultrasonography-mammography (6,7). Mammography carried out in organized screening situations is typically administered only to female patients aged 50-74 years, but can be requested outside organized breast cancer screening under certain conditions, including the presence of certain symptoms, including pain or a mass (25, 26) . Ultrasound is the recommended initial diagnostic test administered to young female patients, due to the high density of the breast tissue rendering the mammography images challenging to analyze. Younger female patients generally have denser breast tissue than older female patients. This variation is due to the physiological modification of the breast over the course of life, with decreased water overload and fibro glandular tissue becoming proportionately less important than fatty tissue (27) .
In conclusion, the present study demonstrated that cases of breast cancer in female patients ≤35 years of age are frequent in Togo, despite unavailability of a national cancer registry and immunohistochemistry techniques. These breast cancer cases are predominantly infiltrative ducal carcinoma of the breast, typically diagnosed in the advanced stages. These cases of breast cancer in young female patients require attention with regard to early diagnosis for adequate therapeutic management, particularly in countries with limited resources. The results indicate a genetic origin and warrant a thorough search. In addition, collaboration with other pathologists and institutions is required in future studies.
